# Proprio

> Proprio is a Seattle medical technology company building an AI-powered surgical navigation platform, Paradigm, that uses light field imaging, computer vision, and machine learning to give surgeons a continuous, radiation-free 3D view of anatomy during spine surgery. Spun out of the University of Washington in 2016, the company fuses live intraoperative sensing with preoperative scans - a capability it calls Volumetric Intelligence - to improve precision, capture surgical data, and build a foundation model for surgery.

- **Founded:** 2016
- **Headquarters:** Seattle, Washington, United States
- **Founders:** Gabriel Jones (Co-founder & CEO), Dr. Samuel Browd (Co-founder, Neurosurgeon (Seattle Children's Hospital)), Joshua Smith (Co-founder, University of Washington Professor (computer vision & sensor systems)), James Youngquist (Co-founder, Computer Vision Specialist)
- **Team size:** ~70 employees (2026); ~40-51 in 2023
- **Products:** Proprio Paradigm, Volumetric Intelligence, Picasso, Surgical dataset / foundation model
- **Notable:** First light field-enabled spine surgery navigation platform to receive FDA 510(k) clearance (2023)., Completed the world's first light field-enabled spine surgery using AI-driven technology., Reached 50 successful surgeries on the Paradigm platform and unveiled a large surgical dataset.

## Products & services

- **Proprio Paradigm** — An AI-powered surgical navigation platform that uses light field imaging, computer vision, and machine learning to generate a continuous, real-time, radiation-free 3D view of the patient's anatomy and the surgical scene during spine surgery.
- **Volumetric Intelligence** — Proprio's core capability that fuses high-definition multimodal intraoperative sensor data with preoperative CT/MRI scans to give surgeons live 3D visualization, measurement, and guidance without added radiation.
- **Picasso** — A Paradigm feature that received Proprio's fourth FDA clearance, extending the platform's intraoperative 3D measurement and visualization capabilities.
- **Surgical dataset / foundation model** — A large, structured dataset captured from real procedures used to train AI models for surgery, including segmentation, planning, and intraoperative guidance.

## Achievements

- First light field-enabled spine surgery navigation platform to receive FDA 510(k) clearance (2023).
- Completed the world's first light field-enabled spine surgery using AI-driven technology.
- Reached 50 successful surgeries on the Paradigm platform and unveiled a large surgical dataset.
- Secured a fourth FDA clearance (Picasso feature) in January 2026.
- Raised roughly $74-78M in total funding from investors including DCVC, Intel, and HTC.

## Latest updates

- **2026-01** — FDA granted clearance for Proprio's Picasso feature, the company's fourth FDA-cleared capability within the Paradigm platform.
- **2024-09** — Proprio announced it had completed 50 surgeries on Paradigm and unveiled a massive surgical dataset for training AI.
- **2023-11** — Completed the world's first light field-enabled spine surgery using the Paradigm platform.
- **2023-07** — Raised $43M Series B to fuel commercialization of its 3D surgical navigation system.
- **2023-04** — Received first FDA 510(k) clearance for the Paradigm surgical navigation platform.

## Links

- Website: https://propriovision.com
- LinkedIn: https://www.linkedin.com/company/proprio-vision
- Twitter/X: https://twitter.com/Proprio_Vision

---

Profile page: https://yespress.io/proprio
Published by YesPress — https://yespress.io
Last updated: 2026-07-18